Regeneron Pharmaceuticals REGN
$ 743.35
0.0%
Quarterly report 2024-Q3
added 10-31-2024
Regeneron Pharmaceuticals Financial Statements 2011-2024 | REGN
Annual Financial Statements Regeneron Pharmaceuticals
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
100 B | 83.6 B | 66.8 B | 52 B | 36.7 B | 45.3 B | 40.4 B | 36.1 B | 43.3 B | 41.9 B | 28.7 B | 16.5 B | 8.05 B |
Shares |
107 M | 107 M | 106 M | 108 M | 109 M | 108 M | 106 M | 105 M | 103 M | 101 M | 97.9 M | 94.7 M | 90.6 M |
Historical Prices |
939 | 781 | 632 | 483 | 375 | 374 | 376 | 367 | 543 | 410 | 275 | 171 | 55.4 |
Net Income |
3.95 B | 4.34 B | 8.08 B | 3.51 B | 2.12 B | 2.44 B | 1.2 B | 896 M | 636 M | 348 M | 424 M | 750 M | -222 M |
Revenue |
13.1 B | 12.2 B | 16.1 B | 8.5 B | 7.86 B | 6.71 B | 5.87 B | 4.86 B | 4.1 B | 2.82 B | 2.1 B | 1.38 B | 446 M |
Cost of Revenue |
- | - | - | - | 403 M | 238 M | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | 7.08 B | 6.28 B | 5.48 B | 4.56 B | 3.71 B | 2.61 B | 1.95 B | 1.29 B | 442 M |
Operating Income |
4.05 B | 4.74 B | 8.95 B | 3.58 B | 2.21 B | 2.53 B | 2.08 B | 1.33 B | 1.25 B | 824 M | 743 M | 458 M | -205 M |
Interest Expense |
73 M | 59.4 M | 57.3 M | 56.9 M | 30.2 M | 28.2 M | 25.1 M | 7.2 M | 14.2 M | 37.4 M | 46.4 M | 45.3 M | 21.3 M |
EBITDA |
4.47 B | 5.08 B | 9.23 B | 3.81 B | 2.42 B | 2.68 B | 2.23 B | 1.44 B | 1.33 B | 891 M | 801 M | 495 M | -174 M |
Operating Expenses |
- | - | - | - | 4.87 B | 3.74 B | 3.4 B | 3.23 B | 2.46 B | 1.78 B | 1.19 B | 836 M | 647 M |
General and Administrative Expenses |
2.63 B | 2.12 B | 1.82 B | 1.35 B | 1.83 B | 1.56 B | 1.32 B | 1.18 B | 839 M | 505 M | 329 M | 211 M | 117 M |
All numbers in USD currency
Quarterly Income Statement Regeneron Pharmaceuticals
2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
108 M | 108 M | 108 M | 106 M | 107 M | 107 M | - | 107 M | 108 M | 107 M | - | 106 M | 105 M | 105 M | - | 106 M | 110 M | 110 M | - | 109 M | 109 M | 109 M | - | 108 M | 108 M | 108 M | - | 107 M | 106 M | 106 M | - | 105 M | 105 M | 104 M | - | 103 M | 103 M | 102 M | - | 101 M | 100 M | 98.7 M | - | 98.2 M | 97.7 M | 96.9 M | - | 95 M | 94.6 M | 93.4 M | 90.7 M | 91 M | 90.4 M | 89.2 M |
Net Income |
1.34 B | 1.43 B | 722 M | 1.01 B | 968 M | 818 M | - | 1.32 B | 852 M | 974 M | - | 1.63 B | 3.1 B | 1.12 B | 1.15 B | 842 M | 897 M | 625 M | 792 M | 670 M | 193 M | 461 M | 820 M | 595 M | 551 M | 478 M | 174 M | 388 M | 388 M | 249 M | 253 M | 265 M | 196 M | 181 M | 155 M | 210 M | 195 M | 76 M | 90.1 M | 90.1 M | 90.1 M | 90.1 M | 96.8 M | 141 M | 87.4 M | 98.9 M | 470 M | 191 M | 76.7 M | 11.7 M | -53.4 M | -62.4 M | -62.5 M | -43.4 M |
Revenue |
3.72 B | 3.55 B | 3.14 B | 3.36 B | 3.16 B | 3.16 B | - | 2.94 B | 2.86 B | 2.97 B | - | 3.45 B | 5.14 B | 2.53 B | 2.42 B | 2.29 B | 1.95 B | 1.83 B | 1.86 B | 1.74 B | 1.58 B | 1.37 B | 1.93 B | 1.66 B | 1.61 B | 1.51 B | 1.58 B | 1.5 B | 1.47 B | 1.32 B | 1.23 B | 1.22 B | 1.21 B | 1.2 B | 1.1 B | 1.14 B | 999 M | 870 M | 802 M | 726 M | 666 M | 626 M | 610 M | 597 M | 458 M | 440 M | 415 M | 428 M | 304 M | 232 M | 123 M | 103 M | 108 M | 112 M |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
1.18 B | 1.07 B | 751 M | 1.11 B | 1.02 B | 947 M | - | 1.22 B | 1.11 B | 1.26 B | - | 1.85 B | 3.35 B | 1.11 B | - | 1.05 B | 656 M | 700 M | - | 738 M | 316 M | 480 M | - | 627 M | 622 M | 567 M | - | 560 M | 550 M | 431 M | - | 363 M | 292 M | 329 M | - | 392 M | 345 M | 284 M | 216 M | 824 M | 216 M | 216 M | - | 237 M | 158 M | 153 M | - | 202 M | 87.5 M | 22.2 M | - | -58.5 M | -60.3 M | -41 M |
Interest Expense |
327 M | 573 M | 16.1 M | 17.6 M | 85.3 M | 18 M | - | 15.3 M | 13.1 M | 13.6 M | - | 14.2 M | 14.4 M | 14.6 M | - | 26.3 M | 9.7 M | 6.1 M | - | 7.8 M | 8 M | 7.7 M | - | 7.4 M | 6.9 M | 6.4 M | - | 6.18 M | 5.4 M | 7.5 M | - | 3.58 M | 1.88 M | 3.48 M | - | 1.72 M | 2.75 M | 6.17 M | - | 9.23 M | 10.2 M | 11.6 M | - | 11.7 M | 11.4 M | 11.7 M | - | 11.4 M | 11.2 M | 11.2 M | - | 4.06 M | 4.05 M | 3.72 M |
EBITDA |
- | - | 866 M | - | - | 1.05 B | - | 1.46 B | 1.11 B | 1.33 B | - | 2.06 B | 3.35 B | 1.18 B | - | 1.23 B | 771 M | 756 M | - | 894 M | 419 M | 531 M | - | 732 M | 692 M | 604 M | - | 671 M | 624 M | 469 M | - | 439 M | 340 M | 352 M | - | 444 M | 376 M | 300 M | 216 M | 862 M | 240 M | 227 M | - | 267 M | 177 M | 162 M | - | 230 M | 105 M | 30.6 M | - | -35.3 M | -45.4 M | -34 M |
Operating Expenses |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
714 M | 759 M | 689 M | 640 M | 652 M | 601 M | - | 529 M | 476 M | 450 M | - | 445 M | 415 M | 406 M | - | 327 M | 348 M | 367 M | - | 304 M | 295 M | 291 M | - | 369 M | 365 M | 331 M | - | 307 M | 307 M | 297 M | - | 270 M | 292 M | 290 M | - | 210 M | 175 M | 159 M | 175 M | 519 M | 175 M | 175 M | - | 97.6 M | 72.5 M | 77.3 M | - | 46.9 M | 47.7 M | 58.4 M | - | 32.9 M | 24.6 M | 23.4 M |
All numbers in USD currency